Comparing EU Vs. US Accelerated Pathway Approval Times Makes Senior UK Regulator 'Slightly Defensive'

Record-setting US Blincyto approval is case in point for discussion; EMA/MHRA official Robert Hemmings says EU review structure taps into expertise from "the whole of the continent," plus rapporteurs' independent views.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America